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There is data on connection between the immune system dysfunction and 
the development of epilepsy. Results 
of clinical observations indicate the 
immune system dysfunction in patients 
with Rasmussen encephalitis [15] and 
Lennox-Gastaut syndrome. [4] Patients 
with epilepsy were reported to have 
elevated concentrations of interleukin-6 
[6] in the cerebrospinal liquor, as 
well as the increasing concentrations 
of antagonists regarding receptors to 
interleukin-1 (IL-1) after tonic-clonic 
seizures [8].
Experimentally reproduced kainate-
induced status epilepticus caused 
the growth of the intrahippocampal 
expression of mRNA IL-1, tumor 
necrosis factor (TNF) - alpha and other 
cytokines [7]. It was also shown that IL-1 
introduction prolonged the period of 
kainate-induced seizures manifestation 
[12]. Both cytokines - TNF and IL-1 
enhanced pentylenentetrazol seizures in 
mice [7].
Cytokines are likely to be able to 
modulate the excitability of the brain 
processes, and also to regulate the 
development of seizures, development 
and destruction of neurons, reactive 
gliosis and processes of nerve fi bers 
“sprouting” [9, 11, 13, 14].
Considering the data given above, we 
have conducted a series of experiments 
aimed at determination of the role of 
cytokines under the conditions of the 
genetic model of the absence form of 
epilepsy and chronic kindling-induced 
seizure activity.
Purpose. 
Substantiation of the formation of 
pathological disintegration of the nervous 
and immune systems through the study 
of the effect of TNF and IL-1 expression 
and frequency of spike-wave discharges 
(SWD) generation in WAG/Rij rats (with 
genetically determined absence form of 
epilepsy). An additional objective of the 
work was to determine the pathogenic 
role of the cytokine immune system in 
the electrical kindling by determining the 
infl uence of exogenous introduction of 
TNF on the content of the studied cytokines 
in the rat blood and brain tissue within the 
model of chronic convulsive syndrome.
Materials and methods.
Experimental studies were 
conducted under the conditions of 
chronic experiment on Wistar, WAG / 
Rij and ACI male rats with weight from 
180 to 320 g. Work with experimental 
animals was carried out in compliance 
with fundamental ethical and regulatory 
requirements, and provided by the 
European Commission for Supervision 
of laboratory and other experiments 
involving experimental animals of 
different species, the Law of Ukraine 
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Fig.1. The effect of TNF and IL-1 on the duration of SWD generation in rats 
with genetically determined epilepsy of the absence form
Notes: The vertical dashed line separates the dark (the fi rst 6 hours of the follow-up) 
from the light period of the day 
(the remaining 12 hours of the follow-up after injection of cytokines).
* - P <0.05, ** - P <0.01 and *** - P <0.001 - reliable discrepancies of the studied 
indices compared to rats in the control group (ANOVA statistical double criterion).
PATHOLOGICAL DYSREGULATIVE INTEGRATION OF NEURAL AND IMMUNE 
SYSTEMS IN CASE OF CHRONIC CONVULSIVE SYNDROME
R.S. Vastyanov, Doctor of Medicine, Full Professor
Yu.S. Strelnikova, Assistant of Professor
Odessa State Medical University, Odessa, Ukraine
The paper contains the data related to the authors’ experimental trials, which revealed the infl uence of cytokines – tumour necrosis factor-alpha 
(TNF) and interleukin-1-beta (IL-1) – on different forms of seizure syndrome initiation, progression and suppression. The modulating infl uence 
of cytokines on the development and termination of seizures is discussed together with the cytokines-induced changes of TNF and IL-1 levels in 
blood plasma and brain of infected rats. The authors made a conclusion about pathophysiologic mechanisms of the chronic convulsive syndrome 
accenting on the development of pathological dysregulative integration of neural and immune systems in case of experimental chronic convulsive 
syndrome formation, progression and termination.
Keywords: chronic convulsive syndrome, cytokines, tumour necrosis factor, interleukin-1, pathophysiologic mechanisms, dysregulative 
pathology.
Conference participants
 http://dx.doi.org/10.18007/gisap:msp.v0i11.1499
22
“On protection of animals from cruelty” 
of 21.02.2006, №3447-IV), and 
Commission on Bioethics of ONMedU 
(minutes N28 D of 9 November, 2012).
A model of electrical stimulation 
kindling was used to reproduce chronic 
convulsive syndrome by electric irritation 
of the tonsil through nichrome bipolar 
electrodes (0.10-0.15 mm in diameter 
and interelectrode distance of 0.20-0.30 
mm), which were implanted in advance 
using a stereotactic technique [2]. In 
some series of kindlings exogenous 
introductions of TNF in the dose of 5.0 
mg/kg were made in rats.
Investigation of TNF and IL-1 
content was carried out in the blood and 
brain tissue of WAG/Rij and ACI rats, 
using the ELISA method with selective 
antibodies of the “Biotrak” system 
(Amersham Pharmacia Biotech, USA). 
Each determination was performed 
twice. Absorption of the antibodies was 
performed at a wavelength of 405 nm. 
The minimum specifi ed level was 4.0 
pg/ml. In each investigation of IL-1 
content 0.416 mg of the tissue in the 50 
ml of the tested solution were used. In 
the investigation of the TNF content the 
volume of the tissue was 10 times less.
The results obtained were calculated 
statistically. Minimum statistical 
signifi cance was determined at p <0.05.
Results and discussion.
In 1 hour after intraperitoneal 
injection of the saline solution the 
duration of SWD generation in WAG/Rij 
rats was 161 ± 12 s, in 2 hours the index 
was 184 ± 14 s, after which the decrease 
of the studied index was recorded 
(Fig. 1). During further follow-up (light 
period of the day) the duration of SHP 
generation did not change signifi cantly 
and was between 35 ± 4 up to 85 ± 9 s.
After the injection of IL-1 during the 
dark period of the follow-up there was a 
signifi cant increase in the studied indices. 
In 1 hour after cytokine injection the 
duration of SWD generation in WAG/Rij 
rats was 46% as compared to the same 
period in control rats (p <0.05). In 2 hours 
of the follow-up the studied index value 
was maximum - 96% as compared to that of 
WAG/Rij rats, which were injected with the 
saline solution (p <0.001). During further 
follow-up the duration of SWD generation 
in rats, which were injected with IL-1, was 
signifi cantly higher than the corresponding 
indices in the control group of rats on the 
3rd hour (2.3-fold, p <0.01), on the 
4th hour (4, 2-fold, p <0.01), on the 5th hour 
(2.6 times, p <0.001) of the experiment 
(Fig. 1).
During the fi rst 6 hours of the follow-
up after the TNF injection (the dark period 
of the experiment) the duration of SWD 
generation in rats of both groups did not 
differ signifi cantly as well (p > 0.05). But 
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Fig. 2. The duration of SWD generation (averaged over 2 hours) for 72 hours 
after injection of TNF and IL-1 to rats with genetically determined absence 
form of epilepsy
Notes: The vertical dashed lines separate the dark period of the day 
(the fi rst 6 hours of the follow-up during the day) from the light period of the day 
(from the 7th to 18th day of the follow-up).
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in 7 hours after injection of cytokine the 
duration of SWD generation in WAG/
Rij rats was by 66% higher as compared 
to the same period in control rats 
(p <0.01). In 8 and 9 hours of the 
follow-up the studied index values were 
3.4 times and 2.7 times higher, 
respectively, as compared to the same 
index in WAG/Rij rats, which were 
injected with the saline solution (in both 
cases p <0.001; Fig. 1).
During further follow-up (from 10 to 
18 hrs, the light period of the experiment) 
the duration of SWD generation in 
rats, which were injected with the TNF, 
exceeded considerably the corresponding 
indices in the control rats on average by 
1.5 times (the 12th hr, p <0.01) - 2.7 times 
(the 10th hr, p <0.01; Fig. 1).
The effect obtained during the fi rst 
day continued (Fig. 2) in registration of 
the SWD duration  during the 2nd and 
the 3rd days after the injection of the 
studied cytokines, which showed non-
randomness of the registered dynamics 
of changes in the SWD duration in WAG/
Rij rats after injection of IL-1 and TNF 
during the 1st day. 
At 2-3 months WAG/Rij rats showed 
the average number of SWD at 2.2 ± 1.1, 
and their duration was on an average 
11.6 ± 2.5. In the control group of the 
follow-up (ASI rats of the similar age) 
spike-wave discharges could not be 
registered (Fig. 3). At 6-7 months WAG/
Rij rats showed signifi cantly higher 
average number of SWD (5.3-fold, 
p <0.001), as compared to the index in 
WAG/Rij rats aged 2-3 months. The 
SWD duration in WAG/Rij rats aged 
6-7 months was 3.6 times higher than the 
corresponding index in these rats aged 
2-3 months (p <0.001). ASI rats showed 
minimal values of the studied indices 
(Fig. 3).
Convulsive reactions in rats induced 
by electrical stimulation within tonsil 
testing in 24 hours after exogenous TNF 
injection were of generalized tonic-
clonic nature, with the development of 
post-attack depression and autonomic 
disorders (Table).
While studying the dynamics of 
the TNF concentration in the blood and 
brain tissues of kindling rats before and 
after exogenous injection of investigated 
cytokines, its signifi cant increase in the 
blood was registered (6.3-fold, p<0.01). 
Injection of TNF was accompanied 
by the signifi cant (1.9 times, p <0.01) 
growth of its content in the brain tissue 
(Fig. 4, A).
Under the studied conditions a 
similar dynamics of changes in the IL-1 
concentration in the blood and brain of 
kindled rats was revealed (Fig. 4, B).
Thus, the results obtained indicate 
a signifi cant increase in the cytokine 
concentration in the brain and plasma of 
rats with a tonsil kindling. This should 
expand the results of examination of 
changes in TNF levels in WAG/Rij 
rats, genetically predisposed to absence 
seizures at the age of 2-6 months [3]. 
It was found out that the investigated 
cytokine content did not differ in the 
brain of WAG/Rij rats aged 2 months 
from the similar data in the control 
ASI rats. However, in the brain of 
the same rats aged 4 months the TNF 
levels have increased by 24%, while the 
corresponding indices have decreased 
Fig. 4. The infl uence of i.p. TNF injection (5.0 mg/kg) on the content of TNF 
and IL-1 levels (fragment A) and the brain tissue (fragment B) of kindled rats.
Note: * - P <0.05 and ** - P <0.01 - reliable discrepancies of the studied indices 
compared to those in kindled rats before the TNF injection (ANOVA statistic 
criterion + Newman-Keuls). 
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by 12% in the brain of the control rats. 
Thus, the content of the investigated 
cytokine in brain of WAG/Rij rats aged 
4 months was by 27% higher than the 
corresponding index in the control rats. 
Later on, on the 6th month of life indices of 
the TNF level did not differ signifi cantly. 
Taking into account that WAG/Rij 
rats have maximum expressiveness 
of absence seizures at the age of 
2-4 months, it is possible that there may 
be concurrence between the TNF content 
and intensity of the convulsive syndrome 
under the conditions of genetic model of 
generalized absence seizures, indicating 
a pro-convulsive role of this cytokine.
These data are consistent with the 
results of a series of experiments aimed 
at studying the effect of exogenously 
injected IL-1 on the SWD generation 
duration within the experimental model 
of genetically determined absence form 
of epilepsy. The cytokine injected to 
the intact WAG/Rij rats has increased 
durability of SWD generation in the 
fi rst 5 hours after injection. The animals’ 
brain activity was observed during 
72 hours, and duration of SWD 
generation has also increased infl uenced 
by the other cytokine - TNF during the 
7th to the 18th hr since the introduction. 
Thus, there were obtained different 
temporal characteristics of effects of two 
cytokines investigated on the duration 
of SWD. Perhaps, IL-1 increased the 
durability of SWD generation, increasing 
the infl ow of calcium ions into the 
cells through interaction with NMDA-
receptors. There may also be a mediated 
mechanism for implementation of this 
effect – by increasing the production 
of β-endorphins, which in their turn 
have increased the duration of SWD 
generation. Taking into consideration the 
“delayed” effect of TNF on the studied 
index, it seems that its effect was not 
a primary one, and was most likely 
induced by the effect of IL-1.
The investigations have revealed the 
signifi cant growth of the TNF concentration 
in the brain and plasma of rats with tonsil 
kindling. The data indicates substantial 
disorders of the regulatory processes in 
the nervous and immune system in chronic 
EpA, which is an additional evidence for 
the formation of disintegration pathology 
in the studied conditions. We believe that in 
the chronic convulsive syndrome induced 
disintegration of the central nervous system 
is an essential compensatory activation of 
the immune system, which is actually a 
manifestation of cytokine release.
But in terms of electrical 
stimulation of the cerebellar tissue the 
TNF concentrations in the cerebral 
cortex and cerebellum did not differ 
signifi cantly from those of a control 
group [10]. That is, while determining 
the TNF concentrations in tissues of 
the various brain formations under the 
conditions of electrical stimulation of 
the tonsil and cerebellum we expected 
to obtain different results, as the tonsil 
and cerebellum are related to different 
entities as to their possible impact 
on epileptogenesis. It is known that 
due to electrical stimulation of the 
tonsil EpA is triggered [2, 5], while in 
electrical stimulation of the cerebellum 
anticonvulsant effects are shown [1]. 
Most likely the primary effect is the 
increased synthesis of TNF in kindling, 
which then causes the increase in the 
synthesis and release of IL-1.
Proconvulsive effects of these 
cytokines are likely to be related to 
facilitation of the distribution process 
of EpA, but not to the reduced threshold 
of seizures occurrence. Our data that 
showed similar concentrations of TNF 
in conditions of the tonsil kindling in 
the cerebral cortex and parts of the 
limbic system (known for low threshold 
in initiation of convulsive reactions), 
and also in the cerebellum tissue [14] 
indicate possible involvement of these 
brain structures in the process of kindling 
seizure formation.
The enhancement of kindling seizure 
expression under the infl uence of TNF 
was proved, which indicated the fact that 
this compound disturbed, fi rst of all, the 
central mechanisms of seizure generation. 
Perhaps such impact also provides an 
increased level of the TNF concentration 
in the blood. However, the fi nal issue as 
to the primacy of the epileptogenic action 
of TNF in blood or brain has not been 
solved yet. Moreover, the demonstrated 
central effects of the investigated 
cytokine after its intraperitoneal injection 
indicate the fact of its permeability 
through the hemo-encephalic barrier 
in kindling convulsions, confi rming 
the assumptions about the connection 
between infl ammation and seizures, on 
the one hand, and the hemo-encephalic 
barrier permeability disturbances and 
convulsions on the other hand.
Conclusions. 
1. The development of chronic 
seizures occurs with involvement of the 
immune system, such as members of the 
family of proinfl ammatory cytokines 
of tumor necrosis factor alpha and 
interleukin-1-beta.
Tab.
The effect of the intraperitoneal injection of TNF (5.0 mkg/kg) on the convulsive reaction in rats 
with electric kindling of the tonsil
Peptides The number of rats and intensity of 
seizures
Р, as
compared to the 
control 
Duration of kindling-induced 
epileptoid activity, M±m,sec.
0 1 2 3 4 5
Kindling, n=11 0 0 0 0 7 4 - 47.3±5.3
Kindling+TNF, n=9 0 0 0 0 2# 7# <0.05 92.5±10.5***
Notes: reliable discrepancies of seizure intensity were counted using the statistical criterion of Kruskal-Wallis test.
# - P <0.05 - reliable discrepancies of the studied index compared to the same data in kindled rats without injection of TNF 
(test statistic criterion of Kruskal-Wallis).
*** - P <0.001 - reliable discrepancies of the studied index compared to the same data in kindled rats without injection of TNF 
(ANOVA statistic criterion).
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2. The exogenous introduction of tumor 
necrosis factor alpha to kindled rats causes 
proconvulsive effect with development of 
generalized tonic-clonic repeated attacks, 
increasing the amplitude-frequency 
characteristics of the electrical activity of 
the cortex and subcortical structures of the 
brain, increasing its concentration in the 
blood and brain tissue, and also increasing 
the interleukin 1 content in the blood and 
brain tissues.
3. One of the major 
pathophysiological mechanisms of 
chronic seizures is the formation of 
abnormal disregulative integration of the 
nervous and immune systems.
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